Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Date:2/23/2012

e income taxes59,955(36,777)307,428150,370Income tax expense (benefit)21,013(12,317)108,03958,496Net income (loss)$ 38,942$ (24,460)$ 199,389$   91,874Net income (loss) per shareBasic$
.28$
(0.18)$
.43$
.73Diluted$
.24$
(0.18)$
.15$
.54Cash dividends declared per common share$
-$
-$
.60$
.00Shares used to compute income (loss) per basic share139,680139,542139,663126,578Shares used to compute income (loss) per diluted share167,683139,542177,441178,801PDL BIOPHARMA, INC.RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP(Unaudited)(In thousands, except non-GAAP net income per diluted share amounts)Three Months Ended December 31,Year Ended
December 31,2011201020112010Net income (loss)

$ 38,942$ (24,460)$ 199,389$   91,874Add back:Legal settlement expense, net of estimated taxes

-60,125-60,125(Gain) loss on retirement or conversion of convertible notes, net of estimated taxes

-(660)49816,431Amortization of debt discount for May 2015 Notes, net of estimated taxes

696-1,716-Non-GAAP net income

39,63835,005201,603168,430Add back interest expense for implied conversion of convertible notes included in determination of fully diluted shares, net of estimated taxes

1,1221,1055,5445,087Non-GAAP income used to compute non-GAAP net income per diluted share

$ 40,760$  36,110$ 207,147$ 173,517Shares used to compute net income per diluted share

167,683139,542177,441178,801Adjustment to shares issued to induce note conversion to common stock (1)

-(185)-(73)Effect of dilutive stock options(2)

-12--Restricted stock outstanding(2)

-115--Assumed conversion of 2012 Notes(2)

-23,399--Assumed conversion of February 2015 Notes(2)

-16,777--Shares used to compute non-GAAP net income per diluted share

167,683179,660177,441178,728Non-GAAP net income per diluted share

$

'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Ondine Biopharma Announces Second Quarter 2008 Financial Results
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
7. Therapure Biopharma Inc. opens for business with first client contracts
8. Top Biopharma Company Adopts BioFortis Translational Research Software for Centralized Management and Mining of Clinical Biomarker Data
9. China Biopharma Effects 1 for 100 Reverse Stock Split
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Best Sanitizers, Inc., a leader ... processing industry, is asking industry professionals to prepare for ... the E2 soap they’re currently using to the Best ... Hand hygiene is critical to fighting cross-contamination and ... Six key criteria are identified to evaluate the effectiveness ...
(Date:8/28/2014)... Aug. 28, 2014 ... market research report is available ... Whole Exome Sequencing Market by ... Target Enrichment), by Services (Sequencing), ... by Application (Cancer, Monogenic disorders) ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a ... SoundConnect to support their communication needs with ... web conferencing platform GlobalMeet powered by SoundConnect. The ... SoundConnect delivers award winning “results driven” business ... will be utilizing GlobalMeet powered by SoundConnect ...
Breaking Biology Technology:Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 2Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 3Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 4Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 5Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 6Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 7Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 8Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 9Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 10Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 11Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 12Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 13Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3PrimeSource Chooses SoundConnect as Collaboration Provider 2
... Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... double-blind, placebo-controlled Phase 2a clinical,trial of MEM 3454, ... cognitive impairment associated with schizophrenia (CIAS). The,trial is ... effects,of three doses of MEM 3454 in patients ...
... Amir Avniel, Company,s CEO, Recently Completed Relocation to ... August 10 ,Rosetta Genomics, Ltd. (NASDQ: ROSG), a ... has initiated the expansion of its US operations ... from the company,s,headquarters in Rehovot, Israel, to New ...
... to the Leader in ... Cellular Bioenergetic Profiling, N. BILLERICA, Mass., ... real-time measurement of cellular,bioenergetics in microplates, announced today that former ... Board of,Directors. In this position, Keegan will apply his successful ...
Cached Biology Technology:Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 2Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 3Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia 4Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008 2Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008 3Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors 2
(Date:8/28/2014)... complex systems. Their infrastructure equipment requires ancillary sub-systems ... to supply fuel, and ICT systems for control ... is interconnected with a wider network and they ... scientists has studied various aspects of inter-network dependencies, ... in EPJ B by Gaihua Fu from Newcastle ...
(Date:8/28/2014)... 25 million kilometres of new roads will be built ... into Earth,s last wildernesses, where they bring an influx ... Now, an ambitious study has created a ,global roadmap, ... to balance the competing demands of development and environmental ... layer that estimates that natural importance of ecosystems and ...
(Date:8/28/2014)... world to Global Warming, has called for atmospheric CO ... says that Carbon Capture, combined with limits on fossil ... warming getting out of control over the next fifty ... call during his presentation to the International Carbon Conference ... discuss Carbon Capture and Storage. , He was ...
Breaking Biology News(10 mins):Inter-dependent networks stress test 2Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2
... Genome Research's cover story for Oct. 2 tells a ... deeply into the long history of maize and rice. ... fuel the fires of the genetically modified organism (GMO) ... in which nature inserts genes much like modern biotechnologists ...
... virus (RYMV) was first identified in 1966 in Kenya. ... where rice is grown. The disease is characterized by ... the leaves. The fertility and development of seeds are ... , Transmission of RYMV occurs by way of insect ...
... time of Ghengis Khan could form the basis of ... is a known source of biologically active chemicals and ... health drinks and various cosmetics. Juice extracted using current ... have developed a highly efficient technique to extract large ...
Cached Biology News:Genome archaeology illuminates the genetic engineering debate 2Discovery of the first resistance gene to rice yellow mottle virus 2Discovery of the first resistance gene to rice yellow mottle virus 3
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
... (1995) • This book is unique ... and molecular techniques currently used in ... analysis of virus-specific antibodies and clinical ... covering immunoassays, blotting and hybridization procedures, ...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Bovine Serum...
Biology Products: